Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Adenocarcinoma; Prostatic Neoplasms Phase 1/Phase 2 ClinicalTrials
CONTENTS